Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot P01024: Variant p.Asp549Asn

Complement C3
Gene: C3
Feedback?
Variant information Variant position: help 549 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance
Residue change: help From Aspartate (D) to Asparagine (N) at position 549 (D549N, p.Asp549Asn). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from medium size and acidic (D) to medium size and polar (N) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help 1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page
Variant description: help In C3D; impairs secretion; variant confirmed at protein level. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 549 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 1663 The length of the canonical sequence.
Location on the sequence: help FRLVAYYTLIGASGQREVVA D SVWVDVKDSCVGSLVVKSGQ The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences. 
Human                         FRLVAYYTLIGASGQREVVADSVWVDVKDSCVGSLVVKSGQ

Mouse                         FRLVAYYTLIGASGQREVVADSVWVDVKDSCIGTLVVKGDP

Rat                           FRLVAYYTLIGANGQREVVADSVWVDVKDSCVGTLVVKGDP

Pig                           FRLVAYYTLIAANGQREVVADSVWVDVKDSCVGTLVVKGGG

Bovine                        FRLVAYYTLINAKGQREVVADSVWVDVKDSCMGTLVVKNGG
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 23 – 1663 Complement C3
Chain 23 – 667 Complement C3 beta chain
Beta strand 544 – 554



Literature citations
Inherited human complement C3 deficiency. An amino acid substitution in the beta-chain (Asp549 to Asn) impairs C3 secretion.
Singer L.; Whitehead W.T.; Akama H.; Katz Y.; Fishelson Z.; Wetsel R.A.;
J. Biol. Chem. 269:28494-28499(1994)
Cited for: VARIANT C3D ASN-549; Quantitative detection of single amino acid polymorphisms by targeted proteomics.
Su Z.D.; Sun L.; Yu D.X.; Li R.X.; Li H.X.; Yu Z.J.; Sheng Q.H.; Lin X.; Zeng R.; Wu J.R.;
J. Mol. Cell Biol. 3:309-315(2011)
Cited for: VARIANT ASN-549; IDENTIFICATION BY MASS SPECTROMETRY;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.